Aehr Test Systems

AEHR is in an early/fragile Stage 1 consolidation and has just recorded a momentum breakout above its base, but with price now extended above the rising EMAs, tactical timing favors waiting for a shallow pullback into EMA support before participating in the continuation.

• ↑Q4 FY’26 revenue set to rise 32.6% YoY to $18.7M
• ↑Multiple follow-on FOX-XP orders highlight strong AI data center demand
• ↓Profitability challenges persist with EPS at -$0.01 and low margins